|
1
|
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
|
Proc Natl Acad Sci U S A
|
1995
|
5.66
|
|
2
|
Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition.
|
Proc Natl Acad Sci U S A
|
1999
|
4.05
|
|
3
|
Cost-effectiveness of detecting and treating diabetic retinopathy.
|
Ann Intern Med
|
1996
|
2.46
|
|
4
|
Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth.
|
J Clin Invest
|
1996
|
2.36
|
|
5
|
Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform.
|
Diabetes Care
|
1994
|
2.30
|
|
6
|
Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes.
|
Invest Ophthalmol Vis Sci
|
2000
|
2.05
|
|
7
|
Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1).
|
Am J Pathol
|
2000
|
2.03
|
|
8
|
Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy.
|
Am J Ophthalmol
|
1997
|
1.92
|
|
9
|
Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.
|
Diabetes Metab Rev
|
1997
|
1.86
|
|
10
|
Lightning-induced ocular injury.
|
Arch Ophthalmol
|
1995
|
1.81
|
|
11
|
High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes.
|
Diabetes Care
|
1999
|
1.78
|
|
12
|
Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox.
|
Diabetes
|
1999
|
1.76
|
|
13
|
Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells.
|
J Biol Chem
|
2000
|
1.67
|
|
14
|
Stereo nonmydriatic digital-video color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy.
|
Ophthalmology
|
2001
|
1.65
|
|
15
|
Perforating ocular fishhook injury.
|
Arch Ophthalmol
|
1992
|
1.54
|
|
16
|
Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells.
|
Diabetes
|
1998
|
1.38
|
|
17
|
Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells.
|
Diabetes
|
1995
|
1.35
|
|
18
|
Possible contribution of hyalocytes to idiopathic epiretinal membrane formation and its contraction.
|
Br J Ophthalmol
|
2009
|
1.31
|
|
19
|
Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study.
|
Ophthalmology
|
2007
|
1.25
|
|
20
|
Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells.
|
J Clin Invest
|
1995
|
1.24
|
|
21
|
Glucose induced genes in bovine aortic smooth muscle cells identified by mRNA differential display.
|
FASEB J
|
1994
|
1.20
|
|
22
|
Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension.
|
Diabetes
|
2001
|
1.20
|
|
23
|
Detecting and treating retinopathy in patients with type I diabetes mellitus. Savings associated with improved implementation of current guidelines. American Academy of Ophthalmology.
|
Ophthalmology
|
1991
|
1.18
|
|
24
|
Angiogenesis and ophthalmic disease.
|
Angiogenesis
|
1999
|
1.15
|
|
25
|
Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells.
|
Invest Ophthalmol Vis Sci
|
1996
|
1.06
|
|
26
|
Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway.
|
Diabetes
|
1999
|
1.03
|
|
27
|
Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence.
|
J Biol Chem
|
1998
|
1.03
|
|
28
|
Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes.
|
Diabetes
|
1996
|
1.02
|
|
29
|
Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells.
|
Invest Ophthalmol Vis Sci
|
1996
|
1.02
|
|
30
|
A specific increased expression of insulin receptor substrate 2 in pancreatic beta-cell lines is involved in mediating serum-stimulated beta-cell growth.
|
Diabetes
|
1998
|
0.96
|
|
31
|
Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells.
|
Diabetes
|
1998
|
0.95
|
|
32
|
von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes.
|
Diabetes Care
|
2000
|
0.86
|
|
33
|
Dipeptide metalloendoprotease substrates are glucose transport inhibitors and membrane structure perturbants.
|
Biochemistry
|
1986
|
0.86
|
|
34
|
Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
|
Invest Ophthalmol Vis Sci
|
2000
|
0.86
|
|
35
|
Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition.
|
Diabet Med
|
2001
|
0.84
|
|
36
|
Vascular endothelial growth factor and the eye. Past, present and future.
|
Arch Ophthalmol
|
1996
|
0.84
|
|
37
|
Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor.
|
J Clin Invest
|
2000
|
0.84
|
|
38
|
Keeping in touch with angiogenesis.
|
Nat Med
|
2000
|
0.83
|
|
39
|
Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissue.
|
J Clin Invest
|
1995
|
0.82
|
|
40
|
Vascular endothelial growth factor expression in canine peripheral vein bypass grafts.
|
J Vasc Surg
|
1997
|
0.81
|
|
41
|
Angiogenic factors in diabetic ocular disease: mechanisms of today, therapies for tomorrow.
|
Int Ophthalmol Clin
|
1998
|
0.80
|
|
42
|
Canthaxanthine retinopathy.
|
Arch Ophthalmol
|
1999
|
0.79
|
|
43
|
Isolation of genes differentially expressed at the downstream anastomosis of prosthetic arterial grafts with use of mRNA differential display.
|
J Vasc Surg
|
1995
|
0.77
|
|
44
|
Regression activity that is naturally present in vitreous becomes ineffective as patients develop proliferative diabetic retinopathy.
|
Diabetologia
|
2013
|
0.76
|
|
45
|
Pigmented fundus lesions in a preterm infant with familial adenomatous polyposis.
|
Arch Ophthalmol
|
1993
|
0.76
|
|
46
|
Relation of optical coherence tomography and unusual angiographic leakage patterns in central serous chorioretinopathy.
|
Eye (Lond)
|
2007
|
0.75
|
|
47
|
Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy.
|
Eye (Lond)
|
2008
|
0.75
|
|
48
|
Closure of macular hole following vitrectomy for diabetic tractional macular detachment.
|
Eye (Lond)
|
2006
|
0.75
|
|
49
|
Preservation of vision through Weiss ring after dense vitreous hemorrhage.
|
Am J Ophthalmol
|
1999
|
0.75
|
|
50
|
Diabetic retinopathy.
|
Ann Acad Med Singapore
|
2000
|
0.75
|